A256940 logo

Keeps Biopharma Inc. Stock Price

KOSDAQ:A256940 Community·₩210.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A256940 Share Price Performance

₩10,500.00
4800.00 (84.21%)
₩10,500.00
4800.00 (84.21%)
Price ₩10,500.00

A256940 Community Narratives

There are no narratives available yet.

Recent A256940 News & Updates

Is Keeps Biopharma (KOSDAQ:256940) Using Too Much Debt?

Sep 06
Is Keeps Biopharma (KOSDAQ:256940) Using Too Much Debt?

Not Many Are Piling Into Keeps Biopharma Inc. (KOSDAQ:256940) Stock Yet As It Plummets 27%

Aug 01
Not Many Are Piling Into Keeps Biopharma Inc. (KOSDAQ:256940) Stock Yet As It Plummets 27%

Market Participants Recognise Keeps Biopharma Inc.'s (KOSDAQ:256940) Revenues Pushing Shares 43% Higher

Jun 17
Market Participants Recognise Keeps Biopharma Inc.'s (KOSDAQ:256940) Revenues Pushing Shares 43% Higher

Is Keeps Biopharma (KOSDAQ:256940) A Risky Investment?

May 15
Is Keeps Biopharma (KOSDAQ:256940) A Risky Investment?

Further Upside For Keeps Biopharma Inc. (KOSDAQ:256940) Shares Could Introduce Price Risks After 33% Bounce

Apr 18
Further Upside For Keeps Biopharma Inc. (KOSDAQ:256940) Shares Could Introduce Price Risks After 33% Bounce

A Piece Of The Puzzle Missing From KPS Corporation's (KOSDAQ:256940) 33% Share Price Climb

Feb 06
A Piece Of The Puzzle Missing From KPS Corporation's (KOSDAQ:256940) 33% Share Price Climb

KPS (KOSDAQ:256940) Takes On Some Risk With Its Use Of Debt

Jan 13
KPS (KOSDAQ:256940) Takes On Some Risk With Its Use Of Debt

Keeps Biopharma Inc. Key Details

₩148.4b

Revenue

₩124.9b

Cost of Revenue

₩23.4b

Gross Profit

₩24.7b

Other Expenses

-₩1.2b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-61.82
Gross Margin
15.79%
Net Profit Margin
-0.84%
Debt/Equity Ratio
77.6%

Keeps Biopharma Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

1 Risk
0 Rewards

About A256940

Founded
2000
Employees
28
CEO
Young Kim Ha
WebsiteView website
www.kpscorp.co.kr

Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products. The company is also involved in bio research and development business; waste battery recycling; and other non-ferrous metal smelting, refining, and alloy manufacturing. The company was formerly known as KPS Corporation and changed its name to Keeps Biopharma Inc. in April 2025. Keeps Biopharma Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

South Korean Market Performance

  • 7 Days: 3.3%
  • 3 Months: 13.9%
  • 1 Year: 32.6%
  • Year to Date: 44.6%
Over the last 7 days, the market has risen 3.3%, driven by gains of 7.0% in the Information Technology sector. The market is up 33% over the last 12 months. As for the next few years, earnings are expected to grow by 24% per annum. Market details ›